Latest News about HALO
Recent news which mentions HALO
From Benzinga
Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion
July 13, 2023
From Benzinga
Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis
June 21, 2023
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
Stocks That Hit 52-Week Lows On Monday
May 08, 2023
From Benzinga
From Benzinga
5 Analysts Have This to Say About Halozyme Therapeutics
February 22, 2023
Tickers
HALO
From Benzinga
From Benzinga
Nasdaq Rises Over 1%; CommVault Systems Shares Plummet
January 11, 2023
From Benzinga
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 11, 2023
From Benzinga
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday
January 11, 2023
From Benzinga
US Stocks Open Higher; Nasdaq Rises 60 Points
January 11, 2023
From Benzinga
5 Analysts Have This to Say About Halozyme Therapeutics
December 08, 2022
Tickers
HALO
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
November 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
From Benzinga
4 Analysts Have This to Say About Halozyme Therapeutics
November 22, 2022
Tickers
HALO
From Benzinga
Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review
November 22, 2022
From Benzinga
Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
November 14, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.